chronic myeloid leukemia in chronic phase research hub

With Ponatinib on the track for treatment-free-remission in chronic myeloid leukemia

This study looks at whether a medicine called Iclusig (ponatinib) can help people with a type of blood cancer called chronic myeloid leukaemia (CML) reach a point where no disease can be found, possibly leading to stopping treatment. It will check how well it works and if it's safe.